Insights
Filter By
All Topics
Advocacy
Affordability
Analytics
Biosimilars
Commercialization
COVID-19
Data
Distribution
Engagement
Legislation
Market access
Medication adherence
Medication therapy management
Oncology
Patient care
Patient support services
Policy
Product access
Regulatory
Reimbursement
Research
Specialty pharmacy
Technology
Third-party logistics
Sort By
Date (Newest to Oldest)
Date (Oldest to Newest)
Title (A-Z)
Title (Z-A)
Filter
Innomar Strategies
Time-to-treatment initiation (TTI) in community infusion clinics - decreasing wait times for Canadian oncology patients
Innomar Strategies
May 2020
Explore More by Topic
Advocacy
Affordability
Analytics
Biosimilars
Commercialization
COVID-19
brand="Cencora" culture="EN" env="Development" tracker="False"